Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysis

Karassa, Fotini B., Afeltra, Antonella, Ambrozic, Ales, Chang, Deh‐Ming, De Keyser, Filip, Doria, Andrea, Galeazzi, Mauro, Hirohata, Shunsei, Hoffman, Ilse E. A., Inanc, Murat, Massardo, Loreto, Mathieu, Alessandro, Mok, Chi Chiu, Morozzi, Gabriella, Sanna, Giovanni, Spindler, Alberto J., Tzioufas, Athanasios G., Yoshio, Taku, Ioannidis, John P. A.·2006·Arthritis & Rheumatism

Abstract

Objective: To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P proteins (anti‐P) for neuropsychiatric systemic lupus erythematosus (NPSLE) in general, for psychosis, mood disorder, or both, and for other diffuse manifestations. Methods: This international meta‐analysis combined standardized data from 1,537 lupus patients contributed by 14 research teams. Weighted estimation of sensitivity and specificity with fixed‐effects and random‐effects models, as well as summary receiver operating characteristic (SROC) curve analysis, was used to summarize test performance. The robustness of the overall estimates was examined in sensitivity analyses that included additional studies published up to November 1, 2004 in the Medline, EMBase, and Cochrane databases. Results: Combining the data from the 14 teams, the weighted sensitivity and specificity estimates for the diagnosis of NPSLE were 26% (95% confidence interval [95% CI] 15–42%) and 80% (95% CI 74–85%), respectively. For psychosis, mood disorder, or both, the sensitivity and specificity were 27% (95% CI 14–47%) and 80% (95% CI 74–85%), respectively. For other diffuse manifestations, the sensitivity was 24% (95% CI 12–42%), and the specificity was 80% (95% CI 73–85%). The proportion of patients with anti‐P antibodies did not vary markedly across different presentations of NPSLE. Between‐study heterogeneity was substantial, but the SROC curves were consistent with the weighted estimates. In further analyses that included another 24 published studies, only the sensitivity for psychosis and/or mood disorder was slightly improved, but it was still suboptimal (42% [95% CI 30–53%]); the specificity remained essentially the same (81% [95% CI 76–85%]). Conclusion: Anti‐P antibody testing has limited diagnostic value for NPSLE, and it is not helpful in differentiating among various disease phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.21539

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 227

Metadata

Authors
Karassa, F. B., Afeltra, A., Ambrozic, A., Chang, D., De Keyser, F., Doria, A., Galeazzi, M., Hirohata, S., Hoffman, I. E. A., Inanc, M., Massardo, L., Mathieu, A., Mok, C. C., Morozzi, G., Sanna, G., Spindler, A. J., Tzioufas, A. G., Yoshio, T., & Ioannidis, J. P. A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2005-12-29
Volume
54
Issue
1
Pages
312-324
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2080626208
Cited by
227
References
3
FWCI
5.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysis. https://app.cochat.ai/papers/10.1002/art.21539
The paper
Karassa, F. B., Afeltra, A., Ambrozic, A., Chang, D., De Keyser, F., Doria, A., Galeazzi, M., Hirohata, S., Hoffman, I. E. A., Inanc, M., Massardo, L., Mathieu, A., Mok, C. C., Morozzi, G., Sanna, G., Spindler, A. J., Tzioufas, A. G., Yoshio, T., & Ioannidis, J. P. A. (2006). Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysis. Arthritis & Rheumatism. https://doi.org/10.1002/art.21539

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.